News

Technology News

Asuragen Launches New Molecular Diagnostic Product Line

Monday, December 8, 2008 5:03:00 AM PDT | VentureDeal Staff
Austin, Texas  --  Medical device company Asuragen announced the launch of a line of molecular diagnostic products to help clinically diagnose translocation positive leukemias.

The company claims that clinical validation studies show a 100% diagnostic accuracy comparison to standard cytogenetic methods.

"This launch illustrates the potential of Asuragen's broad menu of leukemia research tools and represents another step towards Asuragen's goal of providing cutting edge clinical products to the global market," said Matt Winkler, chief executive officer.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1